Carola Leuschner
AeroLeads people directory · profile

Carola Leuschner Email & Phone Number

VP R and D at A28 Therapeutics
Location: Greater Houston, United States, United States 7 work roles 1 school
LinkedIn matched
✓ Verified Jun 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
VP R and D
Location
Greater Houston, United States, United States
Company size

Who is Carola Leuschner? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Carola Leuschner is listed as VP R and D at A28 Therapeutics, a company with 6 employees, based in Greater Houston, United States, United States. AeroLeads shows a matched LinkedIn profile for Carola Leuschner.

Carola Leuschner previously worked as VP R&D at A28 Therapeutics and Vice President, Research and Development at A28 Therapeutics. Carola Leuschner holds Doctor Rerum Naturalium, Biochemistry from University Of Hannover Germany.

Company email context

Email format at A28 Therapeutics

This section adds company-level context without repeating Carola Leuschner's masked contact details.

A28 Therapeutics

Review company-level records connected to Carola Leuschner before choosing the right outreach path.

Profile bio

About Carola Leuschner

A highly motivated research and development professional with 20+ years of experience in defining scientific strategy underlying the development of bio therapeutics from bench to bedside, IND submission, deliberate interpersonal development and project management. Recognized for providing mentorship, establishing dynamic expansion of platform technology programs, and pre-clinical testing in vitro and in vivo. Adept in CRO (pre-clinical, clinical, manufacturing, regulatory) management and collaboration with key opinion leaders to identify early discovery and treatment in cancer research for 10+ years. Proficient in invention of new products through original research resulting in proven understanding of scientific literature. Trusted to support positive reinforcement and advancement of talented discovery scientists.

Current workplace

Carola Leuschner's current company

Company context helps verify the profile and gives searchers a useful next step.

A28 Therapeutics
A28 Therapeutics
VP R and D
Houston, TX, US
Employees
6
AeroLeads page
7 roles

Carola Leuschner work experience

A career timeline built from the work history available for this profile.

Vice President, Research And Development

Current

La Jolla, California, US

Jan 2022 - Present

Vp Of R&D

Current
Boko Therapeutics
Mar 2022 - Present

Vp Of Research And Development

Current
  • Successfully implemented 2 clinical trials and passed 11 patents granted in US and international.
  • Developed platform technology (5 drug candidates), 1 from bench to bedside
  • Streamlining expansion of three research programs in two significant medical departments at MD Anderson.
  • Lead representative during drug testing and diligence phases.
  • Co-authored publications on Phase I and Phase II program studies.
  • Managed and identified goals, timelines and deliverables for onboarding research partners and Biology and Pharmacology groups.
Oct 2007 - Present

Associate Professor

Baton Rouge, LA, US

  • Received funding from the Department of Defense to develop a targeted prostate cancer therapy for early metastases using lytic peptide conjugates with $334,744 (2003-2007) budget. Information was presented at the.
  • Received funding from Esperance Pharmaceuticals: Pre-clinical development of lytic peptide conjugates forcancer treatment. October 17, 2006 – October 15, 2007, $ 750,000, PI: Carola Leuschner
  • Grant reviewer in study sections Nanotechnology for Alliance for Nano Health Research Program (NIH), Molecular Imaging and Nano Medicine (SG Komen Foundation) and Human Health and Development at the Kentucky Science.
  • Co-Investigator in a NIH funded study in the Rapid Access to Intervention Development (RAID) program for targeted destruction of prostate, ovarian and testicular cancers and their metastases by a lytic peptide.
  • Published study data in 12 peer reviewed journals, 19 peer reviewed abstracts, 8 invited presentations, 2book chapters that led to 4 patent applications.
Apr 1996 - Sep 2007

Graduate Research Assistant

Institute For Botany
Jan 1989 - Dec 1992
1 education record

Carola Leuschner education

  • University Of Hannover Germany
    University Of Hannover Germany
    Biochemistry
FAQ

Frequently asked questions about Carola Leuschner

Quick answers generated from the profile data available on this page.

What company does Carola Leuschner work for?

Carola Leuschner works for A28 Therapeutics.

What is Carola Leuschner's role at A28 Therapeutics?

Carola Leuschner is listed as VP R and D at A28 Therapeutics.

Where is Carola Leuschner based?

Carola Leuschner is based in Greater Houston, United States, United States while working with A28 Therapeutics.

What companies has Carola Leuschner worked for?

Carola Leuschner has worked for A28 Therapeutics, Boko Therapeutics, Esperance Pharmaceuticals, Inc., Pennington Biomedical Research Center, Baton Rouge La, and Institute For Botany.

How can I contact Carola Leuschner?

You can use AeroLeads to view verified contact signals for Carola Leuschner at A28 Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Carola Leuschner attend?

Carola Leuschner holds Doctor Rerum Naturalium, Biochemistry from University Of Hannover Germany.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.